Literature DB >> 15944538

Cardiovascular magnetic resonance: structure, function, perfusion, and viability.

David C Isbell1, Christopher M Kramer.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15944538     DOI： 10.1016/j.nuclcard.2005.02.001

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  117 in total

1.  Magnetic resonance tagging and echocardiographic response to dobutamine and functional improvement after reperfused myocardial infarction.

Authors:  Christopher M Kramer; Michael J Malkowski; Sunil Mankad; Therese M Theobald; Diana L Pakstis; Walter J Rogers
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Waren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

3.  Magnetic resonance imaging of prosthetic heart valves.

Authors:  R L Soulen; T F Budinger; C B Higgins
Journal:  Radiology       Date:  1985-03       Impact factor: 11.105

4.  Quantification of regional contractile function after infarction: strain analysis superior to wall thickening analysis in discriminating infarct from remote myocardium.

Authors:  M J Götte; A C van Rossum; J T Marcus; C A Visser
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

5.  Regional myocardial strain before and after mitral valve repair for severe mitral regurgitation.

Authors:  R Mankad; C J McCreery; W J Rogers; R J Weichmann; E B Savage; N Reichek; C M Kramer
Journal:  J Cardiovasc Magn Reson       Date:  2001       Impact factor: 5.364

6.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography.

Authors:  E Nagel; H B Lehmkuhl; W Bocksch; C Klein; U Vogel; E Frantz; A Ellmer; S Dreysse; E Fleck
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

7.  Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers.

Authors:  N B Ingels; G T Daughters; E B Stinson; E L Alderman
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

8.  Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.

Authors:  J K Ghali; Y Liao; R S Cooper
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

9.  Electromechanical mapping identifies improvement in function and retention of contractile reserve after revascularization in ischemic cardiomyopathy.

Authors:  Habib Samady; C Joon Choi; Michael Ragosta; Eric R Powers; George A Beller; Christopher M Kramer
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

10.  Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Work in progress.

Authors:  S Schaefer; R van Tyen; D Saloner
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105
View more
  12 in total

Review 1.  Characterization of myocardial viability using MR and CT imaging.

Authors:  Gabriele A Krombach; Thoralf Niendorf; Rolf W Günther; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

2.  Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality.

Authors:  Surya C Gnyawali; Sashwati Roy; Molly McCoy; Sabyasachi Biswas; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

3.  The case for CMR.

Authors:  Peter W Shaw; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

4.  Role of Cardiac MR Imaging in Cardiomyopathies.

Authors:  Christopher M Kramer
Journal:  J Nucl Med       Date:  2015-06       Impact factor: 10.057

Review 5.  Advances in MRI Applications to Diagnose and Manage Cardiomyopathies.

Authors:  Ramya Vajapey; Brendan Eck; Wilson Tang; Deborah H Kwon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-27

6.  Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure?

Authors:  Brian J Schietinger; Szilard Voros; David C Isbell; Craig H Meyer; John M Christopher; Christopher M Kramer
Journal:  Int J Cardiovasc Imaging       Date:  2007-01-10       Impact factor: 2.357

7.  Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.

Authors:  Stijntje D Roes; Theodorus A M Kaandorp; Nina Ajmone Marsan; Jos J M Westenberg; Petra Dibbets-Schneider; Marcel P Stokkel; Hildo J Lamb; Ernst E van der Wall; Albert de Roos; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

8.  Patterns of late gadolinium enhancement in chronic hemodialysis patients.

Authors:  Brian J Schietinger; Glenn M Brammer; Hongkun Wang; John M Christopher; Katherine W Kwon; Amy J Mangrum; J Michael Mangrum; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

9.  Adaptive postprocessing techniques for myocardial tissue tracking with displacement-encoded MR imaging.

Authors:  Han Wen; Keith A Marsolo; Eric E Bennett; Kwame S Kutten; Ryan P Lewis; David B Lipps; Neal D Epstein; Jonathan F Plehn; Pierre Croisille
Journal:  Radiology       Date:  2008-01       Impact factor: 11.105

Review 10.  The expanding role of left ventricular functional assessment using gated myocardial perfusion SPECT: the supporting actor is stealing the scene.

Authors:  Roberto Sciagrà
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.